Alkermes earnings selloff a buying opportunity, says Mizuho

Mizuho analyst Uy Ear lowered the firm’s price target on Alkermes to $36 from $37 and keeps a Buy rating on the shares. The analyst views the company’s overall Q1 print as "solid," given the modest top- and bottom-line beats. However, disappointment in Lybalvi and concerns about its market opportunity led to the post-earnings report selloff, the analyst tells investors in a research note. The firm would buy the stock on the weakness.